Tyra Biosciences

TYRANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.764 B

$25.65 -0.31%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$119.9M

Loss-making

Shares outstanding

59,676,939

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#119Stoke TherapeuticsSTOK$1.81B
#120SepternaSEPN$1.80B
#121Tyra BiosciencesTYRA$1.76B
#122NanobiotixNBTX$1.75B
#123AnaptysbioANAB$1.63B

What if Tyra Biosciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$440,311.84

Per share 17,166× higher

Bitcoin $1.72T

$25,013.17

Per share 975× higher

Nvidia $5.48T

$79,700.14

Per share 3,107× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Tyra Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.